Hepatitis B: A "GLOBAL" Health Challenge

Gastroenterology

Volumn 136, Issue 2, 2009, Pages 389-392

  Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; LIVER ENZYME; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PEGINTERFERON ALPHA2A; PLACEBO; TELBIVUDINE; TENOFOVIR; VIRUS DNA;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; CLINICAL TRIAL; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LONG TERM CARE; MIXED INFECTION; MORTALITY; MYOPATHY; NEPHROTOXICITY; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; VIROLOGY; VIRUS REPLICATION;

EID: 58649108768     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.12.018     Document Type: Editorial

References (19)

1. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR 55 (2006) 1-41
2. Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR 57 (2008) 1-16
3. Kim W.R., Ishitani M.B., and Dickson E.R. Rising burden of hepatitis B in the United States: Should the 'other' virus be forgotten?. Hepatology 36 (2002) 222A (Abstract)
4. Niederau C., Heintges T., Lange S., et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334 (1996) 1422-1427
5. Liaw Y.F., Sung J.J., Chow W.C., et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351 (2004) 1521-1531
6. National Institutes of Health. Consensus Development Conference statement, management of hepatitis B. October 20-22, 2008. http://www.natap.org/2008/HBV/102308_01.htm Accessed November 5, 2008
7. Keeffe E.B., Dieterich K.T., Han S.H.B., et al. A treatment algorithm for the Management of Chronic Hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 6 (2008) 1315-1341
8. Lok A.S.F., and McMahon B.J. AASLD practice guideline: chronic hepatitis B. Hepatology 45 (2007) 507-539
9. Dienstag J.L., Goldin R.D., Heathcote E.J., et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 124 (2003) 105-117
10. Ghany M., and Liang T.J. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132 (2007) 1574-1585
11. Liaw Y.F., Gane E., Leung N., et al. 2-year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 136 (2008) 486-495
12. Chan H.L.Y., Heathcote E.J., Marcellin P., et al. Treatment of hepatitis B e-antigen positive chronic hepatitis with telbivudine or adefovir. Ann Intern Med 147 (2007) 745-754
13. Han S.H., Chang T.T., Chao Y.C., et al. Five years of continuous entecavir for nucleoside-naïve HBeAg (+) chronic hepatitis B: results from study ETV 901. Hepatology 48 4 Suppl 1 (2008) 705A (abstract)
14. Snow-Lampart A., Chappell B.J., Curtis M., et al. Week 96 resistance surveillance for HBeAg positive and negative subjects with chronic HBV infection randomized to receive Tenofovir DF 300 mg q d. Hepatology 48 4 Suppl 1 (2008) 197A (abstract)
15. Van Bommel F., Wunsche T., Mauss S., et al. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 40 (2004) 1421-1425
16. Sung J.J., Lai J.Y., Zeuzem S., et al. Lamivudine compared with lamivudine and adefovir for the treatment of HBeAg positive chronic hepatitis B. J Hepatol 48 (2008) 728-735
17. Lai C.L., Leung N., Teo E.K., et al. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology 129 (2005) 528-536
18. Antiretroviral Pregnancy Registry. www.apregistry.com Accessed October 1, 2008
19. Hammer S.M., Eron J.J., Reiss P., et al. Antiretroviral treatment of adult HIV infection. JAMA 300 (2008) 555-570